OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
April 06, 2017
FDA is in the center of the debate over developing and pricing new cancer therapies.
April 05, 2017
Scott Gottlieb answers Senators' questions at his confirmation hearing before the Senate Health, Education, Labor and Pensions Committee.
April 02, 2017
Industry fears limited benefits as FDA readies voluntary data tracking program.
March 28, 2017
A new report states that wider access to new antivirals for HCV and better screening of patients would help avert 90,000 deaths by 2030.
March 27, 2017
Manufacturers and regulators are working to reach consensus on the harmonization of management of postapproval changes.
March 22, 2017
Will new generic drugs bring the cost of medicines down in the way policy makers hope?